Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.
Truist Securities expressed confidence in its latest note that Merck will be able to navigate the upcoming Gardasil headwinds ...
Reports Q4 revenue $15.6B, consensus $15.51B. “We delivered strong growth in 2024, reflecting demand for our innovative portfolio, including ...
Shares of Merck (NYSE: MRK) were trading lower on Tuesday. The drop comes as the S&P 500 gained 0.5% and the Nasdaq Composite ...
Merck MRK will report its fourth-quarter and full-year 2024 earnings on Feb. 4, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $15.56 billion and $1.72 per ...
When compared against market expectations, Merck’s fourth-quarter results were a mixed bag. The company reported non-GAAP EPS ...
Below are the earnings highlights for MicroStrategy Inc. (MSTR): Earnings: -$670.81 million in Q4 vs. $89.13 million in the same ...
Welcome to the Qualcomm first quarter fiscal 2025 earnings conference call. [Operator instructions] As a reminder, this ...